Intuitive Surgical EBITDA 2010-2022 | ISRG

Intuitive Surgical annual and quarterly EBITDA history from 2010 to 2022. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Intuitive Surgical EBITDA for the quarter ending December 31, 2022 was $0.485B, a 9.89% decline year-over-year.
  • Intuitive Surgical EBITDA for the twelve months ending December 31, 2022 was $1.970B, a 8.53% decline year-over-year.
  • Intuitive Surgical 2022 annual EBITDA was $1.97B, a 8.53% decline from 2021.
  • Intuitive Surgical 2021 annual EBITDA was $2.153B, a 60.32% increase from 2020.
  • Intuitive Surgical 2020 annual EBITDA was $1.343B, a 15.56% decline from 2019.
Intuitive Surgical Annual EBITDA
(Millions of US $)
2022 $1,970
2021 $2,153
2020 $1,343
2019 $1,591
2018 $1,333
2017 $1,173
2016 $1,052
2015 $856
2014 $653
2013 $957
2012 $936
2011 $764
2010 $613
2009 $412
Intuitive Surgical Quarterly EBITDA
(Millions of US $)
2022-12-31 $485
2022-09-30 $496
2022-06-30 $491
2022-03-31 $499
2021-12-31 $538
2021-09-30 $530
2021-06-30 $592
2021-03-31 $493
2020-12-31 $500
2020-09-30 $344
2020-06-30 $148
2020-03-31 $351
2019-12-31 $465
2019-09-30 $420
2019-06-30 $410
2019-03-31 $295
2018-12-31 $368
2018-09-30 $350
2018-06-30 $305
2018-03-31 $310
2017-12-31 $359
2017-09-30 $308
2017-06-30 $281
2017-03-31 $225
2016-12-31 $277
2016-09-30 $288
2016-06-30 $277
2016-03-31 $211
2015-12-31 $278
2015-09-30 $232
2015-06-30 $195
2015-03-31 $151
2014-12-31 $240
2014-09-30 $179
2014-06-30 $160
2014-03-31 $74
2013-12-31 $235
2013-09-30 $199
2013-06-30 $246
2013-03-31 $277
2012-12-31 $240
2012-09-30 $235
2012-06-30 $247
2012-03-31 $214
2011-12-31 $219
2011-09-30 $196
2011-06-30 $184
2011-03-31 $165
2010-12-31 $182
2010-09-30 $142
2010-06-30 $150
2010-03-31 $139
2009-12-31 $137
2009-09-30 $113
2009-06-30 $109
2009-03-31 $53
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $84.237B $6.222B
Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.206B 23.69
Edwards Lifesciences (EW) United States $49.143B 32.69
Alcon (ALC) Switzerland $32.311B 29.57
STERIS (STE) Ireland $17.996B 22.80
Fresenius Medical Care AG KGaA (FMS) Germany $11.408B 11.93
Teleflex (TFX) United States $11.141B 18.17
Penumbra (PEN) United States $10.162B 1565.71
Globus Medical (GMED) United States $5.255B 25.31
Integer Holdings (ITGR) United States $2.448B 18.98
Glaukos (GKOS) United States $2.324B 0.00
Paragon 28 (FNA) United States $1.527B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.330B 17.30
Nevro (NVRO) United States $1.089B 0.00
Artivion (AORT) United States $0.488B 240.60